Show simple item record

dc.contributor.authorRodrigues, Michelle
dc.contributor.authorEzzedine, Khaled
dc.contributor.authorHamzavi, Iltefat
dc.contributor.authorPandya, Amit G.
dc.contributor.authorHarris, John E.
dc.date2022-08-11T08:09:21.000
dc.date.accessioned2022-08-23T16:27:13Z
dc.date.available2022-08-23T16:27:13Z
dc.date.issued2017-07-01
dc.date.submitted2017-07-20
dc.identifier.citationJ Am Acad Dermatol. 2017 Jul;77(1):1-13. doi: 10.1016/j.jaad.2016.10.048. <a href="https://doi.org/10.1016/j.jaad.2016.10.048">Link to article on publisher's site</a>
dc.identifier.issn0190-9622 (Linking)
dc.identifier.doi10.1016/j.jaad.2016.10.048
dc.identifier.pmid28619550
dc.identifier.urihttp://hdl.handle.net/20.500.14038/36731
dc.description.abstractVitiligo is a common autoimmune disease that progressively destroys melanocytes in the skin, resulting in the appearance of patchy depigmentation. This disfiguring condition frequently affects the face and other visible areas of the body, which can be psychologically devastating. The onset of vitiligo often occurs in younger individuals and progresses for life, resulting in a heavy burden of disease and decreased quality of life. Presentation patterns of vitiligo vary, and recognition of these patterns provides both diagnostic and prognostic clues. Recent insights into disease pathogenesis offer a better understanding of the natural history of the disease, its associations, and potential for future treatments. The first article in this continuing medical education series outlines typical and atypical presentations of vitiligo, how they reflect disease activity, prognosis, and response to treatment. Finally, we discuss disease associations, risk factors, and our current understanding of disease pathogenesis.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=28619550&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttps://doi.org/10.1016/j.jaad.2016.10.048
dc.subjectchemical leukoderma
dc.subjectconfetti depigmentation
dc.subjecthalo nevi
dc.subjectleukoderma
dc.subjectsegmental vitiligo
dc.subjectvitiligo
dc.subjectvitiligo pathogenesis
dc.subjectCellular and Molecular Physiology
dc.subjectDermatology
dc.subjectSkin and Connective Tissue Diseases
dc.titleNew discoveries in the pathogenesis and classification of vitiligo
dc.typeJournal Article
dc.source.journaltitleJournal of the American Academy of Dermatology
dc.source.volume77
dc.source.issue1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/metnet_pubs/98
dc.identifier.contextkey10458180
html.description.abstract<p>Vitiligo is a common autoimmune disease that progressively destroys melanocytes in the skin, resulting in the appearance of patchy depigmentation. This disfiguring condition frequently affects the face and other visible areas of the body, which can be psychologically devastating. The onset of vitiligo often occurs in younger individuals and progresses for life, resulting in a heavy burden of disease and decreased quality of life. Presentation patterns of vitiligo vary, and recognition of these patterns provides both diagnostic and prognostic clues. Recent insights into disease pathogenesis offer a better understanding of the natural history of the disease, its associations, and potential for future treatments. The first article in this continuing medical education series outlines typical and atypical presentations of vitiligo, how they reflect disease activity, prognosis, and response to treatment. Finally, we discuss disease associations, risk factors, and our current understanding of disease pathogenesis.</p>
dc.identifier.submissionpathmetnet_pubs/98
dc.contributor.departmentDepartment of Dermatology
dc.source.pages1-13


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record